Topic

Virginia

A collection of 392 issues

Work With Your Doctor to Get Orkambi (lumacaftor/ivacaftor) Covered by Cigna in Virginia: Complete Guide

Answer Box: Getting Orkambi Covered by Cigna in Virginia To get Orkambi (lumacaftor/ivacaftor) approved by Cigna in Virginia, you need: F508del homozygous genotype confirmation, a CF specialist prescription, and prior authorization documentation. The fastest path: (1) Schedule a CF center visit to gather genetic testing and clinical documentation, (2)

How to Get Filspari (sparsentan) Covered by Blue Cross Blue Shield in Virginia: Prior Authorization Guide, Appeals Process, and State Protections

Answer Box: Getting Filspari Covered by Blue Cross Blue Shield in Virginia To get Filspari (sparsentan) covered by Blue Cross Blue Shield in Virginia, you need: (1) confirmed IgA nephropathy diagnosis with UPCR ≥1.5 g/g, (2) REMS program enrollment, and (3) prior authorization showing 90+ days of optimized

Renewing Zokinvy (lonafarnib) Approval with Aetna CVS Health in Virginia: Complete Guide to Prior Authorization Renewal, Appeals, and Bridge Options

Quick Answer: Renewing Your Zokinvy (lonafarnib) Approval Aetna CVS Health typically requires annual prior authorization renewal for Zokinvy (lonafarnib) with updated clinical documentation showing ongoing medical necessity and benefit. Submit your renewal request 30-45 days before your current PA expires to avoid treatment interruption. Required documents include: genetic testing confirmation,

If Garadacimab Isn't Approved by Cigna in Virginia: Formulary Alternatives & Exception Paths (2025 Guide)

Answer Box: Getting HAE Prophylaxis Coverage Through Cigna in Virginia If Cigna denies Garadacimab (Andembry), you have strong alternatives and exception paths. First, try Haegarda (subcutaneous C1-INH) - it's Cigna's preferred first-line prophylaxis and often approved quickly. If that fails or isn't suitable, document

Do You Qualify for Takhzyro Coverage by UnitedHealthcare in Virginia? Decision Tree & Next Steps

Answer Box: Getting Takhzyro Covered by UnitedHealthcare in Virginia You likely qualify for Takhzyro (lanadelumab-flyo) coverage if you have confirmed hereditary angioedema (HAE) with documented C1-INH deficiency and ≥1 attack per month. UnitedHealthcare requires prior authorization through OptumRx with specific lab values and attack documentation. The fastest path: Have your

How to Get Amvuttra (vutrisiran) Covered by Blue Cross Blue Shield in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Amvuttra (vutrisiran) Approved by Blue Cross Blue Shield in Virginia Blue Cross Blue Shield (Anthem) in Virginia requires prior authorization for Amvuttra (vutrisiran) for both hATTR polyneuropathy and ATTR cardiomyopathy. Success depends on: (1) confirmed TTR genetic testing or biopsy results, (2) specialist involvement (neurology/cardiology), and

How to Get iLink® Corneal Cross-Linking Covered by Humana in Virginia: Complete PA Guide & Appeals Process

Answer Box: Getting iLink® Covered by Humana in Virginia Humana Medicare Advantage generally covers FDA-approved iLink® corneal cross-linking for progressive keratoconus when strict medical necessity criteria are met and prior authorization is obtained. The procedure is billed under Part B medical benefits (CPT 0402T), while Photrexa drug coverage falls under

How to Get Juxtapid (lomitapide) Covered by Aetna (CVS Health) in Virginia: Prior Authorization Forms, Appeal Timeline & REMS Requirements

Quick Answer: Fastest Path to Approval Getting Juxtapid (lomitapide) covered by Aetna (CVS Health) in Virginia requires three critical steps: 1) Confirm homozygous familial hypercholesterolemia (HoFH) diagnosis with genetic testing or clinical criteria, 2) Document failure of high-intensity statin + ezetimibe + PCSK9 inhibitor therapy with LDL-C still ≥100 mg/dL, and

If Helixate (Antihemophilic Factor, rFVIII) Isn't Approved by Cigna in Virginia: Formulary Alternatives & Exception Paths

Answer Box: Your Next Steps When Cigna Denies Helixate (rFVIII) When Cigna denies Helixate (antihemophilic factor, rFVIII) in Virginia, you have two main paths: switch to a formulary alternative or file a formulary exception. Most Cigna plans now list Helixate as non-formulary, requiring trial of preferred products like Advate, Kovaltry,

Renewing Opdivo (Nivolumab) Coverage with Aetna (CVS Health) in Virginia: Complete Documentation Guide and Appeal Timeline

Answer Box: Opdivo (Nivolumab) Renewal with Aetna (CVS Health) in Virginia Aetna (CVS Health) requires prior authorization renewal for Opdivo (nivolumab) every 6 months. Submit renewal requests at least 14 days before your current authorization expires via the Availity portal using Novologix. Required documentation includes recent imaging showing no disease